Bolt Biotherapeutics Inc (BOLT) stock is lower by -85.01% since Friday, February 5, 2021 when the stock began trading, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives BOLT stock a score of 30 out of a possible 100.
That rank is primarily influenced by a short-term technical score of 1. BOLT's rank also includes a long-term technical score of 1. The fundamental score for BOLT is 90. In addition to the average rating from Wall Street analysts, BOLT stock has a mean target price of $38.50. This means analysts expect the stock to climb 698.76% over the next 12 months.
BOLT has an Overall Score of 30. Find out what this means to you and get the rest of the rankings on BOLT!
Bolt Biotherapeutics Inc (BOLT) stock has risen 0.31% while the S&P 500 is lower by -0.11% as of 10:41 AM on Wednesday, Dec 8. BOLT has gained $0.01 from the previous closing price of $4.80 on volume of 100,290 shares. Over the past year the S&P 500 has risen 20.45% while BOLT is lower by -85.01%. BOLT lost -$3.15 per share in the over the last 12 months.
Click Here to get the full Stock Report for Bolt Biotherapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
